COCH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Envoy Medical Inc (COCH) is not a strong buy for a beginner, long-term investor at this time. While insider buying activity is a positive catalyst, the company's financial performance is weak, with declining revenue and negative EPS. Additionally, there are no significant technical or trading signals to suggest a strong entry point. The lack of recent news or analyst ratings further limits the visibility of potential growth opportunities.
The MACD is above 0 and positively contracting, indicating mild bullish momentum. RSI is neutral at 61.325, and moving averages are converging, suggesting no clear trend. Key resistance levels are at 0.909 and 0.986, while support levels are at 0.662 and 0.585. Overall, the technical indicators do not provide a strong buy signal.
Insider buying has increased significantly by 55882.60% over the last month, indicating potential confidence from company insiders.
Revenue dropped by 25% YoY in the latest quarter, and EPS declined by 5.41% YoY. There is no recent news or analyst coverage to suggest positive sentiment or upcoming catalysts.
In 2025/Q3, revenue dropped to $42,000, down 25% YoY. Net income improved slightly to -$7,747,000, up 5.54% YoY, but EPS fell to -0.35, down 5.41% YoY. Gross margin improved to -383.33, up 63.87% YoY, but remains negative.
No analyst ratings or price target changes are available for this stock.
